tiprankstipranks
Trending News
More News >
CE Holdings Co., Ltd. (JP:4320)
:4320
Japanese Market

CE Holdings Co., Ltd. (4320) AI Stock Analysis

Compare
0 Followers

Top Page

JP

CE Holdings Co., Ltd.

(4320)

Rating:67Neutral
Price Target:
¥691.00
▲(6.80%Upside)
CE Holdings Co., Ltd. shows strong financial stability with robust balance sheet metrics and consistent revenue growth. However, the company needs to improve profitability and cash flow consistency. Technical analysis suggests mixed signals, with a neutral RSI and mild bullish momentum. The stock's valuation is fair, with a decent dividend yield for investors. The absence of recent earnings call data and corporate events does not impact the score calculation.

CE Holdings Co., Ltd. (4320) vs. iShares MSCI Japan ETF (EWJ)

CE Holdings Co., Ltd. Business Overview & Revenue Model

Company DescriptionCE Holdings Co., Ltd. (4320) is a Japanese company that operates within the healthcare sector. The company primarily focuses on providing information technology solutions and services aimed at enhancing healthcare operations and management. Its core products and services include electronic medical record systems, healthcare information systems, and related IT consulting services that streamline healthcare processes for medical institutions.
How the Company Makes MoneyCE Holdings Co., Ltd. generates revenue through the sale and support of its IT solutions tailored for the healthcare industry. Key revenue streams include the licensing of software solutions such as electronic medical records and healthcare management systems, as well as ongoing maintenance and support services. The company also engages in IT consulting services that help medical institutions optimize their operations. Strategic partnerships with hospitals and healthcare providers play a significant role in expanding its client base and enhancing product offerings, contributing to its overall earnings.

CE Holdings Co., Ltd. Financial Statement Overview

Summary
CE Holdings Co., Ltd. exhibits strong revenue growth and operational efficiency, particularly in EBIT and EBITDA margins. The balance sheet is robust with low leverage and high equity ratios, but profitability and return on equity remain areas for improvement. Cash flow performance is less consistent, necessitating attention to bolster cash generation. Overall, the company is on a stable financial footing with opportunities to enhance returns and cash flow management.
Income Statement
72
Positive
The company has demonstrated consistent revenue growth over the years, with a notable increase from 2020 to 2024. The TTM revenue of 15,180 million yen marks a healthy growth from the previous period. Gross profit margin stands at 23.0% for TTM, indicating efficient cost management. However, the net profit margin is relatively low at 1.8% for TTM, suggesting room for improvement in profitability. EBIT and EBITDA margins are robust at 8.9% and 11.4% respectively, showcasing strong operational performance.
Balance Sheet
80
Positive
The company's balance sheet is stable with a favorable equity position. The debt-to-equity ratio is a conservative 0.33, reflecting prudent financial leverage. ROE for TTM is low at 4.6%, indicating modest returns on equity. The equity ratio is strong at 54.6%, highlighting solid capitalization and low reliance on debt. Overall, the company maintains a healthy balance sheet with good liquidity and low financial risk.
Cash Flow
60
Neutral
Cash flow metrics show mixed results. While there is no reported free cash flow for the TTM, historical data indicate fluctuations. Operating cash flow was positive in prior years, but the recent absence of data limits comprehensive analysis. The free cash flow to net income ratio was modest in previous periods, suggesting potential efficiency improvements in cash flow generation.
Breakdown
TTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income StatementTotal Revenue
15.18B14.55B13.63B13.70B12.28B10.60B
Gross Profit
3.49B3.37B3.69B3.16B2.65B2.02B
EBIT
1.35B1.15B1.25B1.03B879.06M547.07M
EBITDA
1.73B1.24B1.71B1.44B1.36B732.22M
Net Income Common Stockholders
277.92M123.42M687.53M588.00M632.93M173.48M
Balance SheetCash, Cash Equivalents and Short-Term Investments
3.49B3.83B3.14B3.96B2.87B2.81B
Total Assets
11.04B11.25B11.24B10.91B9.46B8.86B
Total Debt
2.02B2.16B1.42B1.89B1.37B2.10B
Net Debt
-1.47B-1.66B-1.72B-2.07B-1.50B-709.47M
Total Liabilities
4.56B4.65B4.66B4.82B3.98B4.02B
Stockholders Equity
6.02B6.10B6.08B5.63B5.07B4.50B
Cash FlowFree Cash Flow
0.0089.90M-46.35M45.64M613.91M567.46M
Operating Cash Flow
0.00752.30M795.82M1.55B1.00B912.58M
Investing Cash Flow
0.00-630.41M-861.72M-763.83M-109.39M-68.24M
Financing Cash Flow
0.00566.46M-754.51M306.64M-838.45M573.79M

CE Holdings Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price647.00
Price Trends
50DMA
636.34
Positive
100DMA
621.90
Positive
200DMA
556.75
Positive
Market Momentum
MACD
1.85
Positive
RSI
49.82
Neutral
STOCH
26.13
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4320, the sentiment is Neutral. The current price of 647 is below the 20-day moving average (MA) of 660.05, above the 50-day MA of 636.34, and above the 200-day MA of 556.75, indicating a neutral trend. The MACD of 1.85 indicates Positive momentum. The RSI at 49.82 is Neutral, neither overbought nor oversold. The STOCH value of 26.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4320.

CE Holdings Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
86
Outperform
¥5.95B9.19
3.07%16.07%72.83%
74
Outperform
¥15.60B9.01
0.62%-12.13%291.07%
67
Neutral
¥10.14B21.20
2.83%9.21%-20.04%
65
Neutral
¥19.58B19.99
1.57%17.20%20.25%
54
Neutral
$5.37B3.35-45.10%2.79%16.77%-0.01%
52
Neutral
¥6.18B
-9.71%-484.01%
43
Neutral
¥15.64B4,465.71
1.63%-7.98%-181.00%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4320
CE Holdings Co., Ltd.
650.00
84.10
14.86%
JP:3628
Data Horizon Co., Ltd.
505.00
-137.00
-21.34%
JP:3671
Softmax Co., Ltd. (Japan)
976.00
234.17
31.57%
JP:3902
Medical Data Vision Co.Ltd.
399.00
-97.34
-19.61%
JP:3939
Kanamic Network Co., LTD.
417.00
-131.38
-23.96%
JP:6095
MedPeer, Inc.
709.00
115.57
19.47%

CE Holdings Co., Ltd. Corporate Events

CE Holdings Reports Strong Financial Growth for H1 2025
May 12, 2025

CE Holdings Co., Ltd. reported a significant increase in its financial performance for the six months ending March 31, 2025, with net sales rising by 14% and operating profit by 66% compared to the previous year. The company also forecasts continued growth for the full fiscal year, indicating a strong market position and positive outlook for stakeholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.